Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01642706
What this trial is testing

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Who this might be right for
Rheumatoid ArthritisOsteoarthritisSystemic Lupus Erythematosus+6 more
University Hospital, Montpellier 240
Early research (Phase 1)Active Not RecruitingNCT05411016
What this trial is testing

KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus

Who this might be right for
Healthy VolunteersSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
Kyowa Kirin Co., Ltd. 157
Testing effectiveness (Phase 2)Study completedNCT00278538
What this trial is testing

Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwestern University 32
Not applicableUnknownNCT06087523
What this trial is testing

Pulmonary Disease Among Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, SystemicPulmonary Disease
Odense University Hospital 200
Not applicableLooking for participantsNCT07251179
What this trial is testing

Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerodermaANCA-associated Vasculitis+2 more
University Hospital, Strasbourg, France 200
Testing effectiveness (Phase 2)Study completedNCT01534403
What this trial is testing

Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 17
Testing effectiveness (Phase 2)Ended earlyNCT02533570
What this trial is testing

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Who this might be right for
Systemic Lupus Erythematosus
Seagen Inc. 20
Large-scale testing (Phase 3)UnknownNCT05339217
What this trial is testing

Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Liu Tian 60
Early research (Phase 1)Not Yet RecruitingNCT07688980
What this trial is testing

Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 92
Very early researchLooking for participantsNCT06711146
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research

Who this might be right for
Systemic Lupus Erythematosus
Zhejiang University 36
Very early researchLooking for participantsNCT07107659
What this trial is testing

Safety and Efficacy of ONT01 in Lupus

Who this might be right for
Lupus Nephritis (LN)Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV+5 more
Hospital for Special Surgery, New York 61
Not applicableStudy completedNCT01180361
What this trial is testing

Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance

Who this might be right for
Rheumatoid Arthritis
NYU Langone Health 176
Large-scale testing (Phase 3)Study completedNCT01395745
What this trial is testing

CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 442
Not applicableStudy completedNCT01914770
What this trial is testing

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 1,016
Not applicableStudy completedNCT02932137
What this trial is testing

Anti-infection of Low-does IL-2 in SLE

Who this might be right for
Systemic Lupus Erythematosus
Peking University People's Hospital 30
Early research (Phase 1)Looking for participantsNCT06917742
What this trial is testing

Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)

Who this might be right for
Healthy VolunteersRheumatoid ArthritisSystemic Lupus Erythematosus
Capstan Therapeutics 64
Not applicableNot Yet RecruitingNCT07252141
What this trial is testing

MiR-101-3p and Autotaxin in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Eman Mohamed Shawky 40
Large-scale testing (Phase 3)WithdrawnNCT05609812
What this trial is testing

Atacicept in Subjects With Active Lupus Nephritis (COMPASS)

Who this might be right for
Lupus Nephritis (LN)
Vera Therapeutics, Inc.
Not applicableStudy completedNCT04786431
What this trial is testing

Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases

Who this might be right for
BiomarkerLipidInflammation+4 more
Universidade Nova de Lisboa 427
Not applicableStudy completedNCT00071175
What this trial is testing

Lupus Genetics Studies

Who this might be right for
Systemic Lupus Erythematosus
Oklahoma Medical Research Foundation 3,460
Next Page